Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Angiopoietin-1 helps hair cells survive and grow, making it a potential treatment for hair loss.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

The KRTAP21-1 gene affects wool yield and can help improve wool production.

Keratoacanthoma changes as it grows, showing different hair follicle characteristics at each stage.

Activin helps skin growth and healing mainly through stromal cells and affects keratinocytes based on its amount.

FAKΔe4 helps cells sense and respond to different stiffness levels in their environment.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

AIMP1 can boost hair growth by increasing stem cell activity.

Targeting DKK3–CKAP4 can help reverse hair loss in androgenetic alopecia.

TPA promotes hair growth by increasing stem cell activity and activating specific cell signals.

The study found nine new hair protein genes in human hair follicles.

Transferrin receptor 1 is essential for normal function in the intestines, pancreas, and skin.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

A20 protein is crucial for normal skin and hair development.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

A peptide from hair follicle stem cells promotes hair growth by activating specific skin cells.

Different hair types in mammals are linked to variations in specific protein genes, with changes influenced by their living environments.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Human hair keratin artificial tendon is a safe and effective tendon substitute.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

mTORC2 is crucial for healthy skin barrier by regulating lipids and filaggrin.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.